Skip to main content
. 2020 Nov 21;163(2):317–329. doi: 10.1007/s00701-020-04652-8

Table 4.

Referrals to neurovascular and spinal multidisciplinary teams

Period Pre-COVID-19 COVID-19 p value
Vascular referral age groups (years) p < 0.01
0–17 7 5
18–65 183 97
> 65 55 59
Vascular diagnosis, total (%) 245 (100.0) 161 (100.0) p < 0.01
Aneurysm(s) 185 (75.5) 132 (82.0)
Previously ruptured 79 (32.2) 22 (13.7)
Unruptured symptomatic 6 (2.4) 4 (2.5)
Unruptured incidental 100 (40.8) 106 (65.8)
AVMa 34 (13.9) 8 (5.0)
Previously ruptured cranial 12 (4.9) 1 (0.6)
Unruptured cranial 20 (44.4) 7 (4.3)
Spinal 2 (0.8) 0 (0.0)
Cavernoma 1 (0.4) 5 (3.1)
Other* 25 (10.2) 17 (10.6)
Vascular treatment
Emergency, clip/coil 6/10 1/17 p > 0.05
Ruptured or dissecting intracranial aneurysm 4/6 1/13
Ruptured or symptomatic AVMa or AVFb 2/4 0/4
Elective, clip/coil 8/9 0/0
Intracranial aneurysms 5/8 0/0
AVMa or AVFb 3/1 0/0
Spinal MDTc referrals, total (%) 526 (100.0) 248 (100.0) p < 0.001
Cauda equina syndrome 21 (4.0) 26 (10.5)
Degenerative spine 505 (96.0) 222 (89.5)
Spinal treatment recommendation (% of total) p > 0.05
Routine outpatient 334 (63.5) 151 (60.9)
Urgent outpatient 24 (4.6) 7 (2.8)
Conservative or other 168 (31.9) 90 (36.3)

*Intracranial haemorrhage—no abnormality, non-aneurysmal subarachnoid haemorrhage, stenosis, family history

aArteriovenous malformation

bArteriovenous fistula

cMultidisciplinary team